UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment...
MONT-SAINT-HILAIRE, QUEBEC (TSX: AXP)(NASDAQ: AXCA), announced today that the Federal Minister of Industry, under the Investment Canada Act, has...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4...
CUSIP NO. 054923107 13G PAGE 1 OF 13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (New) AXCAN PHARMA INC (Name of...
CUSIP NO. 054923107 13G PAGE 1 OF 14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
MONT-SAINT-HILAIRE, QUEBEC (NASDAQ: AXCA) today announced financial results for the first quarter of fiscal 2008. All amounts are in U.S. dollars...
MONT-SAINT-HILAIRE, QUEBEC (TSX: AXP)(NASDAQ: AXCA) announced today that the Superior Court of Quebec has issued a final order approving the Plan...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads